Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report

Detalles Bibliográficos
Autores principales: Huang, Wen-Kuan, Huang, Shih-Chiang, Chen, Chien-Ming, Lin, Po-Hung, Wu, Chiao-En, Chuang, Cheng-Keng, Yeh, Chun-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928762/
https://www.ncbi.nlm.nih.gov/pubmed/36652666
http://dx.doi.org/10.1200/PO.22.00528
_version_ 1784888712335720448
author Huang, Wen-Kuan
Huang, Shih-Chiang
Chen, Chien-Ming
Lin, Po-Hung
Wu, Chiao-En
Chuang, Cheng-Keng
Yeh, Chun-Nan
author_facet Huang, Wen-Kuan
Huang, Shih-Chiang
Chen, Chien-Ming
Lin, Po-Hung
Wu, Chiao-En
Chuang, Cheng-Keng
Yeh, Chun-Nan
author_sort Huang, Wen-Kuan
collection PubMed
description
format Online
Article
Text
id pubmed-9928762
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-99287622023-02-16 Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report Huang, Wen-Kuan Huang, Shih-Chiang Chen, Chien-Ming Lin, Po-Hung Wu, Chiao-En Chuang, Cheng-Keng Yeh, Chun-Nan JCO Precis Oncol Case Reports Wolters Kluwer Health 2023-01-18 /pmc/articles/PMC9928762/ /pubmed/36652666 http://dx.doi.org/10.1200/PO.22.00528 Text en © 2023 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle Case Reports
Huang, Wen-Kuan
Huang, Shih-Chiang
Chen, Chien-Ming
Lin, Po-Hung
Wu, Chiao-En
Chuang, Cheng-Keng
Yeh, Chun-Nan
Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report
title Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report
title_full Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report
title_fullStr Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report
title_full_unstemmed Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report
title_short Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report
title_sort marked response to larotrectinib in pelvic spindle cell sarcoma with concurrent tpm3-ntrk1 fusion and cdk4/mdm2 amplification: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928762/
https://www.ncbi.nlm.nih.gov/pubmed/36652666
http://dx.doi.org/10.1200/PO.22.00528
work_keys_str_mv AT huangwenkuan markedresponsetolarotrectinibinpelvicspindlecellsarcomawithconcurrenttpm3ntrk1fusionandcdk4mdm2amplificationacasereport
AT huangshihchiang markedresponsetolarotrectinibinpelvicspindlecellsarcomawithconcurrenttpm3ntrk1fusionandcdk4mdm2amplificationacasereport
AT chenchienming markedresponsetolarotrectinibinpelvicspindlecellsarcomawithconcurrenttpm3ntrk1fusionandcdk4mdm2amplificationacasereport
AT linpohung markedresponsetolarotrectinibinpelvicspindlecellsarcomawithconcurrenttpm3ntrk1fusionandcdk4mdm2amplificationacasereport
AT wuchiaoen markedresponsetolarotrectinibinpelvicspindlecellsarcomawithconcurrenttpm3ntrk1fusionandcdk4mdm2amplificationacasereport
AT chuangchengkeng markedresponsetolarotrectinibinpelvicspindlecellsarcomawithconcurrenttpm3ntrk1fusionandcdk4mdm2amplificationacasereport
AT yehchunnan markedresponsetolarotrectinibinpelvicspindlecellsarcomawithconcurrenttpm3ntrk1fusionandcdk4mdm2amplificationacasereport

Ejemplares similares